Seda are excited to announce the establishment of its new Swedish presence at Medicon Village, Lund, one of Scandinavia’s leading life science hubs, marking a significant milestone in the company’s continued expansion. 

This positions Seda at the heart of a thriving innovation ecosystem where more than 2,800 researchers, entrepreneurs, and industry experts collaborate across the full life science value chain. Medicon Village’s unique blend of research institutions, start-ups, and established companies provides an ideal environment for Seda to accelerate partnerships, support clients, and advance its mission to improve patient outcomes through cutting-edge solutions. 

Seda’s main point of contact at Medicon Village is Helena Engman. Helena is Senior Principal Scientist, ADME Sciences at Seda with a Master of Pharmacy (MPharm) and a PhD in Biopharmaceutics from the University of Uppsala, Sweden. Helena is an experienced Biopharmaceutics Scientist with recognised experience in Clinical Pharmacology and CMC regulatory with 21 years’ experience in Early and Late-Stage Drug Product Development roles. At Seda, Helena provides scientific advice on Clinical Pharmacology, Biopharmaceutics and Pharmacokinetic Modelling in development plans and for regulatory purposes. 

Chief Scientist and Co-Founder, Paul Dickinson commented – ‘The Nordic countries possess a distinguished legacy of developing breakthrough medicines, underpinned by a strong commitment to scientific excellence that closely aligns with Seda’s philosophy. I am pleased that Helena, who exemplifies these values, will provide a local Swedish presence’. 

Seda’s new location will serve as a strategic base for strengthening relationships with Swedish and regional partners, supporting local initiatives, and expanding access to Seda’s expertise across Pharmaceutical Development, Clinical Pharmacology and GMP Manufacturing. 

With this expansion, Seda reinforces its commitment to supporting innovation in the Nordic life science landscape and driving impactful solutions for healthcare systems and patients across Europe.